Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 187   

Articles published

PFE 29.39 +0.01 (0.03%)
price chart
Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for ...
Tomahawk, WI 08/26/2014 (Basicsmedia) - AstraZeneca plc (ADR) (NYSE:AZN) shares continue to surge in the market after news emerged that Pfizer Inc. (NYSE:PFE) may table another takeover bid with the three-month ban period that prevented the same ...
Pfizer Inc. (NYSE:PFE) Sets Pace With Palbo Even As The Hunt For Tax ...  FinancialsTrend
Pfizer's Neutral Rating Reaffirmed at Zacks (PFE)  sleekmoney
Related articles »  
Growth Prospects Remain Strong For Pfizer
These changes have allowed Pfizer to improve its cash position, which is vital for the strategic growth plans of the company in the long run. These transactions also resulted in better profitability for the company in 2013, clearly showing that the ...
AstraZeneca now tougher target for Pfizer
Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.
AstraZeneca is tougher Pfizer target as possible bid looms  Chicago Tribune
Related articles »  
Pfizer Inc: 5 Bonus Trade Ideas
Pfizer has been pulling back since a top in early March. The last few legs suggest a bounce higher may be in the process now that could take it to 30.30.
Good News For Pfizer And GSK: E-Cigarettes To Be Strictly Regulated
The AHA mentioned that �proven cessation methods� like Nicorette Gum and the NicoDerm CQ patch from GlaxoSmithKline Plc (GSK), or Chantix from Pfizer Inc. (PFE) should be recommended for smokers looking to quit. However, Pfizer's Chantix sales have ...
Pfizer Megadeal Still in Sight After Astra: Real M&A
�We prefer buybacks over takeovers,� said Barry James, who helps oversee $5.5 billion as president of James Investment Research Inc., a Pfizer shareholder in Xenia, Ohio. �I can't say from a strategic point of view if a takeover would be good, but in ...
Related articles »  
Notable Pharma Stocks: Pfizer Inc. (NYSE:PFE), ACADIA Pharmaceuticals Inc ...
Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration has granted Fast Track designation to the company's investigational Clostridium difficile vaccine candidate PF-06425090.
Related articles »  
GSK, Pfizer Subsidiary Gets FDA Approval For HIV Pill
ViiV Healthcare, a small biotech jointly owned by GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE) and Shionogi & Co Ltd (SGIOF), has won the approval of the US Food and Drug Administration (FDA) for its Human Immunodeficiency Virus (HIV) drug ...
Glaxo, Pfizer's ViiV Wins Approval for HIV Combo Drug  Bloomberg
Glaxo's ViiV Healthcare Gets US Approval For HIV Treatment Triumeq  London South East
Related articles »  
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of ...
12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to ...
Pfizer Partners With 23andMe To Research Bowel Disease  Bidness Etc
Pfizer to help 23andMe unravel genetic ties to bowel disease  Reuters
Related articles »  
Will This New Rating Help Pfizer (PFE) Stock Today?
Separately, TheStreet Ratings team rates PFIZER INC as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation: "We rate PFIZER INC (PFE) a BUY. This is driven by some important positives, which we believe ...